OGSIVEO, a drug marketed by Springworks, has fifteen patents and sixty-four patent family members across forty-five countries. The generic ingredient is nirogacestat hydrobromide, supplied by one company. Additional information is available on DrugPatentWatch.
New Penalties is a Push to Mitigate Cybersecurity Threats in Telecommunications and Healthcare
Cybersecurity is a critical issue in critical sectors such as telecommunications and healthcare, as a cyber attack can have far-reaching effects. Despite recent regulatory efforts
